Sustained efficacy of continuous subcutaneous insulin infusion in type 1 diabetes subjects with recurrent non-severe and severe hypoglycemia and hypoglycemia unawareness: A pilot study

Diabetes Technology and Therapeutics

Volumn 12, Issue 7, 2010, Pages 517-521

  Giménez, Marga ^a   Lara, Mercè ^a   Conget, Ignacio ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIET THERAPY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MALE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; TREATMENT OUTCOME; BLOOD; DIABETES MELLITUS, TYPE 1; INFUSION PUMP; METABOLISM; QUESTIONNAIRE;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIA; INFUSION PUMPS, IMPLANTABLE; INSULIN; INSULIN INFUSION SYSTEMS; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 77954435546     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0028     Document Type: Article

References (31)

1. Nathan DM: Management of diabetes mellitus after the DCCT-what's next? West J Med 1995;162:469-470.
2. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. The DCCT Research Group. Am J Med 1991;90:450-459.
3. Cryer PE: Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia 2002;45:937-948.
4. Cryer PE, Davis SN, Shamoon H: Hypoglycemia in diabetes. Diabetes Care 2003;26:1902-1912.
5. Bolli GB: Hypoglycaemia unawareness. Diabetes Metab 1997;23(Suppl 3):29-35.
6. Bolli GB: Treatment and prevention of hypoglycemia and its unawareness in type 1 diabetes mellitus. Rev Endocr Metab Disord 2003;4:335-341.
7. Cryer PE: Hypoglycemia risk reduction in type 1 diabetes. Exp Clin Endocrinol Diabetes 2001;109(Suppl 2):S412-S423.
8. Fritsche A, Stumvoll M, Haring HU, Gerich JE: Reversal of hypoglycemia unawareness in a long-term type 1 diabetic patient by improvement of beta-adrenergic sensitivity after prevention of hypoglycemia. J Clin Endocrinol Metab 2000;85:523-525.
9. Linkeschova R, Raoul M, Bott U, Berger M, Spraul M: Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years. Diabet Med 2002;19:746-751.
10. Bolli GB, Pampanelli S, Porcellati F, Fanelli CG: Recovery and prevention of hypoglycaemia unawareness in type 1 diabetes mellitus. Diabetes Nutr Metab 2002;15:402-409.
11. Cox DJ, Kovatchev B, Koev D, Koeva L, Dachev S, Tcharaktchiev D, Protopopova A, Gonder-Frederick L, Clarke W: Hypoglycemia anticipation, awareness and treatment training (HAATT) reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus. Int J Behav Med 2004;11:212-218.
12. Cox DJ, Gonder-Frederick L, Polonsky W, Schlundt D, Kovatchev B, Clarke W: Blood glucose awareness training (BGAT-2): long-term benefits. Diabetes Care 2001;24:637-642.
13. Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Montori VM: Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and metaanalyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab 2009;94:729-740.
14. Streja D: Can continuous glucose monitoring provide objective documentation of hypoglycemia unawareness? Endocr Pract 2005;11:83-90.
15. Gimenez M, Conget I, Jansa M, Vidal M, Chiganer G, Levy I: Efficacy of continuous subcutaneous insulin infusion in Type 1 diabetes: a 2-year perspective using the established criteria for funding from a National Health Service. Diabet Med 2007;24:1419-1423.
16. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005;28:1245-1249.
17. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, PolonskyW: Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 1995;18:517-522.
18. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970;19:644-655.
19. Ferrer JP, Esmatjes E, Gonzalez-Clemente JM, Goday A, Conget I, Jimenez W, et al.: Symptomatic and hormonal hypoglycaemic responses to human and porcine insulin in patients with type I diabetes mellitus. Diabet Med 1992;9:522-527.
20. McAulay V, Deary IJ, Frier BM: Symptoms of hypoglycaemia in people with diabetes. Diabet Med 2001;18:690-705.
21. Geddes J, Schopman JE, Zammitt NN, Frier BM: Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabet Med 2008;25:501-504.
22. Fanelli CG, Porcellati F, Pampanelli S, Bolli GB: Insulin therapy and hypoglycaemia: the size of the problem. Diabetes Metab Res Rev 2004;20(Suppl 2):S32-S42.
23. Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P: Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 1993;42:1683-1689.
24. Hermanns N, Kulzer B, Kubiak T, Krichbaum M, Haak T: The effect of an education programme (HyPOS) to treat hypoglycaemia problems in patients with type 1 diabetes. Diabetes Metab Res Rev 2007;23:528-538.
25. Pampanelli S, FanelliC, Lalli C, CiofettaM, Sindaco PD, Lepore M, Modarelli F, Rambotti AM, Epifano L, Di Vincenzo A, Bartocci L, Annibale B, Brunetti P, Bolli GB: Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia. Diabetologia 1996;39:677-686.
26. Bott S, Bott U, Berger M, Muhlhauser I: Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia 1997;40:926-932.
27. Schiaffini R, Ciampalini P, Fierabracci A, Spera S, Borrelli P, Bottazzo GF, Crinó A: The Continuous Glucose Monitoring System(CGMS) in type 1 diabetic children is theway to reduce hypoglycemic risk. Diabetes Metab Res Rev 2002;18:324-329.
28. Amiel S: Reversal of unawareness of hypoglycemia. N Engl J Med 1993;329:876-877.
29. Pickup JC, Sutton AJ: Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008;25:765-774.
30. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476.
31. Leitão CB, Tharavanij T, Cure P, Pileggi A, Baidal DA, Ricordi C, Alejandro R: Restoration of hypoglycemia awareness after islet transplantation. Diabetes Care 2008;31:2113-2115.